|Browse All Terms|
|Beginning With||By Language|
|A B C D E F G H I J K L M N O P Q R S T U V W X Y Z :: All||
Antibodies with only one (instead of two) protein chain derived from only one of the domains of the antibody structure. Dabs exploit the finding that, for some antibodies, half of the antibody molecule binds to its target antigen almost as well as the whole molecule. The potential advantages of dabs are that they can be made easily by bacteria or yeasts, and offer a way to clone antibody-like molecules into bacteria, and hence to be able to easily screen millions of antibodies. Related ideas are single-chain antigen binding technology (SCA), biosynthetic antibody binding sites (BABS), minimum recognition units (MRUs), and complementary determining regions (CDRs).
Publication Source: Food and Agricultural Organization of the United Nations (FAO)
Publication Date: 1999
Do you have a term that should be included in the glossary?
Submit a term for review
FDA Office of Pharmaceutical Quality Initiatives & 2016 Priorities
Friday, 24 Jun 2016 12.06
Interdisciplinary Perspectives on Key Pharma Industry Trends
Thursday, 23 Jun 2016 15.06
Endless Opportunities to Expand Your Knowledge & Network
Wednesday, 22 Jun 2016 12.06